The University of Minnesota College of Pharmacy was awarded $26 million in total research funding for fiscal year 2022. According to the American Association of Colleges of Pharmacy (AACP), this positions the college with a national ranking of eighth in total research funding.
“The expertise of our faculty and staff spans a wide range of disciplines and therapeutic areas and their commitment to our research mission is exceptional,” said Dean Lynda Welage. “Within our unique research enterprise our research and scholarship is focused on making a difference in Minnesota and the world.”
Adds Dr. Carolyn Fairbanks, associate dean for research, “Our faculty’s expertise enables the progression of a therapy from molecule design through pharmacological evaluation, to dosage form formulation to clinical trial and implementation. Our faculty provide international and national leadership in pharmaceutical technology, precision medicine, community engagement and health economics among many other important topic areas.”
Fairbanks notes that in 2022, college faculty were recognized as leaders in innovation locally, nationally, and internationally for cutting-edge discoveries. The BBC Science Focus Magazine News listed Dr. Gunda Georg's program on developing new contraceptives as the first of 19 of the most "mind-blowing science stories of 2022.”
“Our research enterprise is accelerating as our faculty are laser-focused on solving the world's greatest challenges.”
AACP’s annual research report compiles research data from more than 140 colleges of pharmacy around the country. The rankings are based on the federal fiscal year which runs October 1 through September 30.